SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $31 Million in Gross Proceeds

GlobeNewswire
2025.10.27 13:38
portai
I'm PortAI, I can summarize articles.

纽约，2025 年 10 月 27 日（GLOBE NEWSWIRE）-- SELLAS 生命科学集团公司（NASDAQ：SLS）（“SELLAS” 或 “公司”），一家专注于开发针对广泛癌症适应症的新型疗法的晚期临床生物制药公司，今天宣布立即

Source: GlobeNewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.